The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EphB4-EphrinB2 receptor-ligand pair as a novel target in prostate cancer (PC).
 
Sarmad Sadeghi
Consulting or Advisory Role - Pfizer
Research Funding - Merck; Pfizer
 
Grace Li
No Relationships to Disclose
 
Imran Siddiqi
No Relationships to Disclose
 
Akash Sali
No Relationships to Disclose
 
Gangning Liang
No Relationships to Disclose
 
Inderbir Gill
No Relationships to Disclose
 
Jacek K. Pinski
No Relationships to Disclose
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer; Pharmacyclics; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Eisai; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi; US Biotest
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Parkash S. Gill
No Relationships to Disclose